UnitedHealth Posts Q1 $7.23 EPS on $111.7B Revenue, Raises Outlook
UnitedHealth Group reported Q1 adjusted EPS of $7.23 versus $6.58 consensus and revenue of $111.7 billion against $109.6 billion estimates. The company raised its full-year profit forecast above $18.25 per share and improved its medical care ratio to 83.9%, spurring an 8.5% stock surge.
1. Q1 Financial Outperformance
UnitedHealth delivered adjusted first-quarter earnings of $7.23 per share on revenue of $111.7 billion, exceeding consensus figures of $6.58 in EPS and $109.6 billion in revenue. This marks a year-over-year EPS increase of over 10% and a revenue gain of roughly 2%.
2. Efficiency Gains Drive Margin
The company improved its medical care ratio to 83.9%, down from 85.2% last year, reflecting tighter cost controls and operational efficiencies across its insurance and services units. Optum Health contributed lower hospital admission rates and disciplined pricing to support margin expansion.
3. Increased Shareholder Returns and Guidance
Management raised the full-year 2026 EPS outlook to above $18.25 from $17.75 and authorized an additional $2 billion share buyback program. The combination of higher guidance and accelerated capital return fueled the stock’s 8.5% jump.
4. Analyst Price Target Revision
An investment firm increased its price target for UnitedHealth to $400 from $350, citing stronger financial health and improved future prospects based on the quarter’s performance and efficiency gains.